Mohamed Zaki - Feb 13, 2025 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Role
Chief Medical Officer
Signature
/s/ Lisa Kallebo, Attorney-in-Fact for Mohamed Zaki
Stock symbol
ADCT
Transactions as of
Feb 13, 2025
Transactions value $
$370,300
Form type
4
Date filed
2/14/2025, 06:22 PM
Previous filing
Dec 9, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADCT Common Shares Award $370K +230K +98.76% $1.61 463K Feb 13, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Shares to be delivered in settlement of a restricted share unit award which vests one-third on the first anniversary of the grant date, which grant date is February 13, 2025, and then one-third on each anniversary date thereafter, upon continued service through the designated vesting event.